Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
Direct Source Verification:
This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients Reuters
Original Source
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-says-its-next-gen-obesity-drug-tops-lilly-rival-late-stage-study-2026-09-21/
